Femasys Inc (FEMY)
1.27
-0.02
(-1.55%)
USD |
NASDAQ |
May 17, 16:00
1.27
0.00 (0.00%)
After-Hours: 20:00
Femasys Profit Margin (Quarterly): -1.33K% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.33K% |
| December 31, 2023 | -2.07K% |
| September 30, 2023 | -1.64K% |
| June 30, 2023 | -902.8% |
| March 31, 2023 | -1.00K% |
| December 31, 2022 | -1.24K% |
| September 30, 2022 | -858.5% |
| June 30, 2022 | -869.0% |
| March 31, 2022 | -897.0% |
| Date | Value |
|---|---|
| December 31, 2021 | -929.8% |
| September 30, 2021 | -838.2% |
| June 30, 2021 | -332.2% |
| March 31, 2021 | -555.0% |
| December 31, 2020 | -590.7% |
| September 30, 2020 | -500.7% |
| June 30, 2020 | -810.7% |
| March 31, 2020 | -845.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.07K%
Minimum
Dec 2023
-332.2%
Maximum
Jun 2021
-953.0%
Average
-869.0%
Median
Jun 2022
Profit Margin (Quarterly) Benchmarks
| Avinger Inc | -263.6% |
| Biolase Inc | -64.01% |
| AIM ImmunoTech Inc | -19.35K% |
| Protalix BioTherapeutics Inc | -122.6% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -107.0% |
| Return on Assets | -78.29% |
| Return on Invested Capital | -94.73% |
| Gross Profit Margin (Quarterly) | 67.35% |
| Operating Margin (Quarterly) | -1.28K% |
| Return on Net Operating Assets | -422.8% |